| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.96B | 22.37B | 22.25B | 21.83B | 16.56B | 6.40B |
| Gross Profit | 7.14B | 6.85B | 5.46B | 6.15B | 2.79B | -1.23B |
| EBITDA | 3.54B | 3.41B | 3.04B | 4.84B | 1.01B | -1.63B |
| Net Income | 794.00M | 644.00M | 1.72B | 2.28B | -1.70B | -3.60B |
Balance Sheet | ||||||
| Total Assets | 33.09B | 31.21B | 31.21B | 30.17B | 29.51B | 30.61B |
| Cash, Cash Equivalents and Short-Term Investments | 6.69B | 5.53B | 6.98B | 8.55B | 7.99B | 8.97B |
| Total Debt | 12.30B | 11.58B | 12.67B | 13.86B | 16.31B | 16.52B |
| Total Liabilities | 30.37B | 28.62B | 28.82B | 29.38B | 31.06B | 30.61B |
| Stockholders Equity | 2.72B | 2.59B | 2.39B | 796.00M | -1.55B | 9.00M |
Cash Flow | ||||||
| Free Cash Flow | 1.24B | 747.00M | 1.29B | 2.76B | 796.00M | -2.64B |
| Operating Cash Flow | 3.93B | 3.66B | 3.93B | 4.32B | 2.37B | -1.56B |
| Investing Cash Flow | -1.05B | -1.00B | -1.36B | -1.83B | -2.50B | -1.87B |
| Financing Cash Flow | -2.17B | -2.37B | -2.87B | -2.37B | -1.61B | 4.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | C$1.53B | 18.22 | 4.83% | 0.93% | 10.42% | 12.81% | |
67 Neutral | C$556.35M | 18.72 | 12.73% | 0.76% | -7.22% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | C$69.11M | 4.24 | 11.06% | ― | 7.42% | 89.31% | |
56 Neutral | C$5.39B | 27.75 | 34.23% | ― | 3.31% | -44.10% | |
52 Neutral | C$1.25B | 72.99 | 4.92% | 1.67% | -2.16% | -69.46% |